Sartorius Stedim (Germany) Today
| 56S1 Stock | EUR 211.80 14.00 7.08% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sartorius Stedim is trading at 211.80 as of the 24th of April 2024. This is a 7.08% increase since the beginning of the trading day. The stock's lowest day price was 211.8. Sartorius Stedim has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sartorius Stedim Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTOR STED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. The company has 92.17 M outstanding shares. More on Sartorius Stedim Biotech
Moving together with Sartorius Stock
| 0.62 | IUI1 | Intuitive Surgical | PairCorr |
Moving against Sartorius Stock
| 0.72 | SG9 | Strix Group Plc | PairCorr |
| 0.49 | DBPD | Xtrackers ShortDAX | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sartorius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sartorius Stedim's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sartorius Stedim or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | OscarWerner Reif |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Sartorius Stedim Biotech (56S1) is traded on Frankfurt Exchange in Germany and employs 11,934 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 28.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sartorius Stedim's market, we take the total number of its shares issued and multiply it by Sartorius Stedim's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sartorius Stedim Biotech operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 92.17 M outstanding shares.
Sartorius Stedim Biotech has accumulated about 164.6 M in cash with 612.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.78.
Check Sartorius Stedim Probability Of Bankruptcy
Ownership AllocationSartorius Stedim maintains a total of 92.17 Million outstanding shares. Sartorius Stedim Biotech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 73.81 % of Sartorius Stedim outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Sartorius Ownership Details
Sartorius Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Sartorius Stedim jumping above the current price in 90 days from now is about 98.0%. The Sartorius Stedim Biotech probability density function shows the probability of Sartorius Stedim stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Sartorius Stedim has a beta of 0.0032. This suggests as returns on the market go up, Sartorius Stedim average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sartorius Stedim Biotech will be expected to be much smaller as well. Additionally, sartorius Stedim Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Sartorius Stedim to move above the current price in 90 days from now is about 98.0 (This Sartorius Stedim Biotech probability density function shows the probability of Sartorius Stock to fall within a particular range of prices over 90 days) .
Sartorius Stedim Biotech Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sartorius Stedim market risk premium is the additional return an investor will receive from holding Sartorius Stedim long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sartorius Stedim. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sartorius Stedim's alpha and beta are two of the key measurements used to evaluate Sartorius Stedim's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.69 | |||
| Standard Deviation | 2.97 | |||
| Variance | 8.81 | |||
| Risk Adjusted Performance | (0.02) |
Sartorius Stock Against Markets
Picking the right benchmark for Sartorius Stedim stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sartorius Stedim stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sartorius Stedim is critical whether you are bullish or bearish towards Sartorius Stedim Biotech at a given time. Please also check how Sartorius Stedim's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sartorius Stedim without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Sartorius Stedim Corporate Directors
Sartorius Stedim corporate directors refer to members of a Sartorius Stedim board of directors. The board of directors generally takes responsibility for the Sartorius Stedim's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Sartorius Stedim's board members must vote for the resolution. The Sartorius Stedim board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Andreas Theisen | Director of Investor Relations | Profile | |
| AnneMarie Graffin | Non-Executive Independent Director | Profile | |
| Henri Riey | Non-Executive Independent Director | Profile | |
| Bernard Lemaitre | Non-Executive Director | Profile |
How to buy Sartorius Stock?
Before investing in Sartorius Stedim, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sartorius Stedim. To buy Sartorius Stedim stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sartorius Stedim. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Sartorius Stedim stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Sartorius Stedim Biotech stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Sartorius Stedim Biotech stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sartorius Stedim Biotech, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Sartorius Stedim Biotech?
The danger of trading Sartorius Stedim Biotech is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sartorius Stedim is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sartorius Stedim. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sartorius Stedim Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Sartorius Stock analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |